Lubrizol Integrates Personal, Home and Health Care Divisions; Now Lubrizol Life Science
New brand to maximize client speed-to-market, providing enhanced solutions
CLEVELAND, July 11, 2019 (GLOBE NEWSWIRE) -- The Lubrizol Corporation announces the reorganization of its Personal, Home and Health Care business lines, integrating them under a newly dedicated brand, Lubrizol Life Science. The change reflects the company’s commitment to evolve with the beauty, health, home and wellness markets, which continue to cross over and converge. The newly formed Lubrizol Life Science team seeks to enhance the value of its solutions and services to customers and end users through its collective expertise in chemistry, applications and market insights.
“Lubrizol Life Science brings together a great variety of formulation and product development experience to sit under one umbrella,” says Lubrizol Advanced Materials President Rick Tolin. “Our internal capabilities are focused and aligned to help our customers quickly meet the expectations of today’s consumers for products that ensure them of a healthier, more beautiful and comfortable life.”
The newly aligned Lubrizol Life Science team is placing a priority on developing and testing products in partnership with customers, engineering breakthroughs and co-driving initiatives that fuel growth. Practices and processes emphasize agile innovation, enabling the organization to act at the speed of a start-up, while responding with the reach, resources and delivery of a global leader. The new brand will also emphasize the proactive innovation needed to bring market-ready solutions to customers, while capitalizing on the reliability of Lubrizol’s 90 years of science and efficacy.
Tolin points out, “Our beauty, health and home customers can count on us bringing truly differentiated products to market, formulated with ingredients that are consumer-driven and backed by the reliability of Lubrizol.” Tolin adds, “The Lubrizol Life Science team is poised to service customers throughout the value chain, from concept to commercialization. Once viewed by customers as a chemical and ingredient supplier, we have evolved into an essential, concept-to-commercialization solutions partner.”
Lubrizol Life Science also plans to add strategic technology, capability and talent by investing to expand its portfolio, including new acquisitions that bring unique opportunities and synergies.
About Lubrizol Life Science
An essential product design, development and manufacturing partner to reputable companies worldwide, helping them to speed their projects to market. The organization proactively leverages its collective consumer market knowledge and scientific expertise across the Beauty, Health and Home business segments to provide innovative, market-ready solutions that fuel customer growth. For more information, visit Lubrizol.com/Life-Science.
About The Lubrizol Corporation
The Lubrizol Corporation, a Berkshire Hathaway company, is a market-driven global company that combines complex, specialty chemicals to optimize the quality, performance and value of customers’ products while reducing their environmental impact. It is a leader at combining market insights with chemistry and application capabilities to deliver valuable solutions to customers in the global transportation, industrial and consumer markets. Lubrizol improves lives by acting as an essential partner in our customers’ success, delivering efficiency, reliability or wellness to their end users. Technologies include lubricant additives for engine oils, driveline and other transportation-related fluids, industrial lubricants, as well as additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for home care, personal care and skin care products and specialty materials encompassing polymer and coatings technologies, along with polymer-based pharmaceutical and medical device solutions.
With headquarters in Wickliffe, Ohio, Lubrizol owns and operates manufacturing facilities in 17 countries, as well as sales and technical offices around the world. Founded in 1928, Lubrizol has approximately 8,700 employees worldwide. Revenues for 2018 were $6.8 billion. For more information, visit Lubrizol.com.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Signify to acquire Cooper Lighting Solutions to strengthen its position in the attractive North American lighting market15.10.2019 22:24:00 CEST | Press release
Press release October 15, 2019 Signify to acquire Cooper Lighting Solutions to strengthen its position in the attractive North American lighting market Signify to acquire Cooper Lighting Solutions from Eaton for USD 1.4 billion in cash Clear strategic fit: Strengthening Signify’s market positions in North America, with increased innovation power and more competitive offerings; Improving the business mix with Professional revenues increasing from 42% to 53% of total sales1 Respective agent networks and front office functions will continue to operate independently Substantial value creation opportunity: cost synergy potential with savings of more than USD 60 million per year, to be largely achieved in the first three years Compelling financial metrics: mid-teens EPS accretion in year 1; transaction ROIC to exceed WACC after year 1 Transaction fully funded with debt; committed bridge financing in place Upon closing of the acquisition: Capital allocation priority is to deleverage. Strong f
Nexstim Plc: Invitation to the Extraordinary General Meeting of Shareholders15.10.2019 17:50:00 CEST | Press release
Nexstim Plc: Invitation to the Extraordinary General Meeting of Shareholders Company announcement, inside information, Helsinki 15 October 2019 at 6.50 PM (EEST) Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") – the company developing and marketing a unique brain stimulation technology for personalized treatment of major depressive disorder (MDD), invites the shareholders to attend the Extraordinary General Meeting of Shareholders of the Company on 11 November 2019 commencing at 10.00 (EEST) at the auditorium of Hotel Haven, Unioninkatu 17 Helsinki, Finland. The reception of persons who have registered for the meeting will commence at 9.30. A. Matters on the agenda of the Extraordinary General Meeting of Shareholders At the Extraordinary General Meeting of Shareholders, the following matters will be considered: 1 OPENING OF THE MEETING 2 CALLING THE MEETING TO ORDER 3 ELECTION OF PERSONS TO SCRUTINIZE THE MINUTES AND TO SUPERVISE THE COUNTING OF VOTES 4 RECORDING THE LEGALI
Nexstim Abp: Kallelse till extra bolagsstämma15.10.2019 17:50:00 CEST | Pressemelding
Nexstim Abp: Kallelse till extra bolagsstämma Pressmeddelande, insiderinformation, Helsingfors 15 oktober 2019, kl. 18.50 (EEST) Nexstim Abp (NXTMH:HEX, NXTMS:STO) (”Nexstim” eller ”Bolaget”), ett företag som utvecklar och marknadsför en unik hjärnstimuleringsteknologi för personlig behandling av egentlig depression (eng. Major Depression Disorder), kallar härmed aktieägarna till extra bolagsstämma 11 november 2019, kl. 10.00 (EEST) i auditoriet på Hotel Haven, Unionsgatan 17 i Helsingfors, Finland. Mottagandet av personer som har registrerat sig för bolagsstämman inleds kl. 9.30. A. Ärenden på extrastämmans dagordning Vid extrastämman ska följande ärenden behandlas: 1 STÄMMANS ÖPPNANDE 2 STÄMMANS KONSTITUERING 3 VAL AV PROTOKOLLJUSTERARE OCH RÖSTRÄKNARE 4 FASTSTÄLLELSE AV ATT STÄMMAN BLIVIT BEHÖRIGEN SAMMANKALLAD 5 FASTSTÄLLANDE AV NÄRVAROLISTA OCH RÖSTLÄNGD 6 STYRELSEKOMMITTÉER OCH INRÄTTANDET AV VALBEREDNINGEN FÖR AKTIEÄGARNA Bolaget har haft två styrelsekommittéer: styrelsens revis
DNO ASA: Mandatory Notification of Trade15.10.2019 17:43:00 CEST | Press release
Oslo, 15 October 2019 - DNO ASA, the Norwegian oil and gas operator, has today purchased 1,100,000 own shares at an average price of NOK 12.6653 per share. Following this transaction, DNO holds 75,500,000 own shares. -- For further information, please contact: Media: email@example.com Investors: firstname.lastname@example.org -- DNO ASA is a Norwegian oil and gas operator focused on the Middle East and the North Sea. Founded in 1971 and listed on the Oslo Stock Exchange, the Company holds stakes in onshore and offshore licenses at various stages of exploration, development and production in the Kurdistan region of Iraq, Norway, the United Kingdom, Netherlands, Ireland and Yemen. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Ress Life Investments A/S publishes Net Asset Value (NAV) per share.15.10.2019 17:20:00 CEST | Press release
Ress Life Investments Holbergsgade 14, 2 tv DK-1057 Copenhagen K Denmark CVR nr. 33593163 www.resslifeinvestments.com To: Nasdaq Copenhagen Date: 15 October 2019 Corporate Announcement 34/2019 Ress Life Investments A/S publishes Net Asset Value (NAV) per share. Ress Life Investments A/S publishes the Net Asset Value (NAV) per share as of 30 September 2019. NAV per share in USD: 1918.35 NAV per share in EUR: 1761.73 The performance during September 2019 was 0.97% in USD. The performance during the month was positively affected by one policy paying out and mark-to-market adjustments. The year-to-date net performance as of 30 September 2019 is 5.76% in USD. Assets under management (AUM) as of 30 September 2019 was 155.1 million US dollars. Questions related to this announcement can be made to the company's AIF-manager, Resscapital AB. Contact person: Gustaf Hagerud email@example.com Tel + 46 8 545 282 27 Note: The terms for subscription of shares, minimum subscription amount
GOGL – Repurchase of shares15.10.2019 16:44:00 CEST | Press release
Golden Ocean Group Limited (“Golden Ocean” or the “Company”) announces that the Company has, on October 15, 2019 purchased 50,000 of the Company's own common stocks. The shares have been bought on the Oslo Stock Exchange at an average price of NOK 53.96 per share. After this transaction Golden Ocean holds a total of 1,250,000 own shares. The transaction is part of the share buyback program announced on December 20, 2018. Hamilton, Bermuda October 15, 2019 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.